US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.11

+0.03740.13%

Post-market: 28.07-0.0374-0.13%16:15 EDT

Volume:278

Turnover:8K

Market Cap:1.41M

PE:- -

High:28.11

Open:28.07

Low:28.11

Close:28.07

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:1.70

T/O Rate:0.56%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Align Technology downgraded to In Line from Outperform at Evercore ISI

Estée Lauder up After Barclays Upgrades to 'overweight'

The EstÉE Lauder Companies : Barclays Raises Target Price to $108 from $97

THOMSON REUTERS

Shares of Estee Lauder up 1.6% Premarket After Barclays Upgrades to 'Overweight'

THOMSON REUTERS

US Research Roundup-Danaher Corporation, Illumina, Reliance

Is Hims & Hers Health (HIMS) A Bargain After The Fraud Lawsuit Claims?

Simply Wall St.

Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)?

Simply Wall St.

Align Technology Inc. Stock Underperforms Friday When Compared to Competitors

AbbVie Joins US Government Pilot to Test Drug Discount Rebates

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,461 Common Shares Worth $100,964.37

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar

THOMSON REUTERS

Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program

THOMSON REUTERS

Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure

Kenvue (KVUE) Stock Still Looks Undervalued On Its 16% Gain

Simply Wall St.

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

AbbVie Says Phase 3 Trials Show Rinvoq Vitiligo Repigmentation Gains Extend to Week 76

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GLAM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.1075,"timestamp":1791489600000,"preClose":28.0701,"halted":0,"volume":278,"hourTrading":{"tag":"盘后","latestPrice":28.0701,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":-0.0374,"changeRate":-0.001331,"amplitude":0},"delay":0,"changeRate":0.0013323785807674948,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Not Yet Opened","change":0.0374,"latestTime":"10-08 16:00:00 EDT","open":28.0701,"high":28.1075,"low":28.1075,"amount":7891,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"exchange":"CBOE","adjPreClose":28.0701,"nav":28.05,"aum":1402500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.0701,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":-0.0374,"changeRate":-0.001331,"amplitude":0},"volumeRatio":1.701348,"impliedVol":0.0781,"impliedVolPercentile":0.0808},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.701348,"shares":50000,"dividePrice":0,"high":28.1075,"amplitude":0,"preClose":28.0701,"low":28.1075,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.1075,"eps":0,"divideRate":0,"volume":278,"delay":0,"ttmEps":0,"open":28.0701,"prevYearClose":25.82,"prevWeekClose":27.6182,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":27.5282,"twentyDayClose":27.7464,"sixtyDayClose":27.8939},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673706761","title":"Align Technology downgraded to In Line from Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2673706761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673706761?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:30","pubTimestamp":1791192608,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Elizabeth Anderson downgraded Align Technology (ALGN) to In Line from Outperform with a price target of $155, down from $220. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/align-technology-downgraded-to-in-line-from-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/align-technology-downgraded-to-in-line-from-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","LU2023250504.SGD","LU1917777945.USD","BK4585","LU2106854487.HKD","LU1974910355.USD","GLAM","LU2023250843.SGD","BK4504","ALGN","BK4588","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673586706","title":"Estée Lauder up After Barclays Upgrades to 'overweight'","url":"https://stock-news.laohu8.com/highlight/detail?id=2673586706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673586706?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:18","pubTimestamp":1791191916,"startTime":"0","endTime":"0","summary":"BUZZ-Estée Lauder up after Barclays upgrades to 'overweight'** Shares of cosmetics maker Estée LauderEL.Nup 2.2% at $93.98 premarket** Brokerage Barclays upgrades stock to \"overweight\" from \"equal weight\"; raises PT to $108 from $97** Says co's projected sales growth, earnings profile over next several years make it among the most attractive companies in the broader global consumer staples index** Notes that after seven quarters since unveiling its turnaround plan, codeliveredmore balanced revenue growth, against expectations that reshaping its operating model would require significant time and investment** Notes growth across regions, sees North America growth to remain elevated in current quarter, structural changes to the operating model could support continued reinvestment while driving EBIT margins into the high teens over time** Average rating of 44 brokerages is \"buy\"; with a median PT of $129- data compiled by LSEG** Up to last close, stock has fallen ~12% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL6N45R0HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU2552382058.USD","LU2552382215.SGD","LU0690374961.EUR","BK4588","EL","BK4183","BK4548","LU1988902786.USD","BK4558","BK4585","LU2404859741.USD","BK4504","LU0690374615.EUR","LU2404859667.USD","LU2264538146.SGD","BK4533","LU2552382132.HKD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673705784","title":"The EstÉE Lauder Companies : Barclays Raises Target Price to $108 from $97","url":"https://stock-news.laohu8.com/highlight/detail?id=2673705784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673705784?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:00","pubTimestamp":1791190829,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nAZN4TND62:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2552382215.SGD","LU2404859667.USD","BK4558","BK4533","BK4504","LU2552382132.HKD","LU0690374615.EUR","LU2404859741.USD","LU0690374961.EUR","LU2552382058.USD","BK4585","EL","LU2264538146.SGD","LU1988902786.USD","BK4548","BK4183","LU1064131342.USD","BK4588","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673705234","title":"Shares of Estee Lauder up 1.6% Premarket After Barclays Upgrades to 'Overweight'","url":"https://stock-news.laohu8.com/highlight/detail?id=2673705234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673705234?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:59","pubTimestamp":1791190762,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45Q03W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","LU2552382215.SGD","LU2264538146.SGD","BK4558","LU2552382132.HKD","LU2552382058.USD","LU1988902786.USD","BK4585","BK4504","LU0690374615.EUR","BK4548","EL","BK4533","LU2404859667.USD","LU0690374961.EUR","BK4588","LU2404859741.USD","LU1064131342.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673770360","title":"US Research Roundup-Danaher Corporation, Illumina, Reliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2673770360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673770360?lang=en_us&edition=fundamental","pubTime":"2026-10-05 15:55","pubTimestamp":1791186918,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Danaher Corporation, Illumina, RelianceOct 5 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Danaher C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMD","AMDY","CHRW","CL","WUGI","AR","BSX","AGCO","AMG","SMH","CAT","BANC","AMRZ","CHD","BXP","AESI","APO","COF","AOSL","GPZ","GLAM","KROP","BFAM","CME","AB","ACM","ALL","ARCB","BAM","BNY","OZK","AMBQ","DHR","CTRE","AXP","CE","CBOE","ALGN","BLK","ASB","BX","CG","FEAM","ADP","AUB","CHRD","XNTK","AIS","BP","ARES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672727360","title":"Is Hims & Hers Health (HIMS) A Bargain After The Fraud Lawsuit Claims?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672727360","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672727360?lang=en_us&edition=fundamental","pubTime":"2026-10-04 14:18","pubTimestamp":1791094706,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in focus after a proposed securities fraud class action accused the telehealth provider of misleading investors about data sharing practices and prescription billing workflows.\nRecent price action for Hims & Hers Health has been choppy, with the share price slipping about 1% over the past day and week, climbing 4.7% over the past month, yet falling 24.2% across 90 days. The 1-year total shareholder return is down 44.8%, despite a very large 3-year gain that...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-hims-hers-health-hims-a-bargain-after-the-fraud-lawsuit-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-hims-hers-health-hims-a-bargain-after-the-fraud-lawsuit-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIYY","HIMZ","GLAM","HIMY","THNR","BK4196","HMYY","HEAL","HIMS","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672474757","title":"Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672474757","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672474757?lang=en_us&edition=fundamental","pubTime":"2026-10-03 10:18","pubTimestamp":1790993925,"startTime":"0","endTime":"0","summary":"Hims & Hers Health recently appointed Kultar Garcha as Chief Medical Officer for the UK and EMEA and Matt Vickers as Chief Medical Officer for Australia, expanding local clinical leadership across key international regions.\nThe move concentrates experienced physicians on clinical quality, patient safety, and prescribing standards, which directly influences how effectively the business can scale personalized care across multiple markets.\nWe will now look at how these new regional Chief...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-new-regional-cmos-altering-the-investment-case-for-hims-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-new-regional-cmos-altering-the-investment-case-for-hims-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","HIMS","HEAL","GLAM","HIMY","HIYY","HMYY","HIMZ","THNR","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741375","title":"Align Technology Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741375","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741375?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:17","pubTimestamp":1790975820,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  slipped 1.10% to $143.74 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's second consecutive day of losses.Align Technology Inc. closed 28.29% below its 52-week high of $200.44, which the company reached on April 21st.The stock underperformed when compared to some of its competitors Friday, as Zimmer Biomet Holdings Inc.  rose 0.26% to $88.29 and Dentsply Sirona Inc.  fell 0.80% to $8.67.Trading volume  remained 365,951 below its 50-day average volume of 915,090.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4198","LU2023250504.SGD","LU0708994859.HKD","LU0006061336.USD","LU0792757196.USD","LU1267930813.SGD","LU0477156953.USD","IE0002270589.USD","LU0128525929.USD","LU1917777945.USD","IE00B7SZLL34.SGD","GLAM","LU0310799852.SGD","LU0889566641.SGD","XRAY","BK4504","LU0211328371.USD","LU1267930573.SGD","BK4534","IE00B19Z3581.USD","LU1267930490.SGD","LU0211327993.USD","LU0029864427.USD","LU0648001328.SGD","LU0130517989.USD","ZBH","BK4566","IE00B19Z3B42.SGD","LU2023250843.SGD","BK4588","LU0980610538.SGD","BK4585","LU0130102774.USD","LU2106854487.HKD","ALGN","LU0310800379.SGD","LU1974910355.USD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749758","title":"AbbVie Joins US Government Pilot to Test Drug Discount Rebates","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749758","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749758?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:51","pubTimestamp":1790974284,"startTime":"0","endTime":"0","summary":"AbbVie joins US government pilot to test drug discount rebatesOct 2 -US drugmaker AbbVieABBV.Nsaid on Friday it would participate in a US government pilot program aimed at testing a new rebate system for discounted medicines.Here are some details:The pilot will begin on January 1, 2027, under the government's 340B program, which helps hospitals and clinics serving low-income patients buy medicines at a discount.Under the new model, eligible healthcare providers will submit claims through a platform called Beacon to obtain 340B pricing on AbbVie's cancer drug Imbruvica, irritable bowel syndrome treatment Linzess and antipsychotic drug Vraylar.AbbVie said it would provide healthcare groups with free access to the system, as well as customer service and special assistance for providers facing operational difficulties.The rebate test will help improve pricing transparency and prevent duplicate discounts as new Medicare-negotiated drug prices take effect, the company said.AbbVie said it pla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","VHT","LU0203347892.USD","LU1983299246.USD","LU0234570918.USD","LU0158827948.USD","LU0708994859.HKD","LU2087621335.USD","PJP","IE0000B7K699.USD","LU1934455194.USD","IE000F7OJYX1.SGD","LU1989772840.SGD","LU0432979614.USD","LU1037948897.HKD","LU2347655156.SGD","LU0320765646.SGD","LU0511384066.AUD","LU0965508806.USD","LU1551013425.SGD","LU0965509283.SGD","IE00B19Z3581.USD","LU0069063385.USD","LU1267930490.SGD","LU1670628061.USD","LU0211327993.USD","LU2357305700.SGD","LU0289961442.SGD","SG9999011175.SGD","IE00BLSP4239.USD","LU0661504455.SGD","LU0823416689.USD","LU0256863902.USD","IE00BJT1NW94.SGD","LU2129689431.USD","TRUH","IXJ","IE00BSNM7G36.USD","LU0203345920.USD","IYH","LU1934455863.HKD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU2129689514.USD","BK4533","LU0124676726.USD","LU0942090050.USD","IE000WAW04H5.SGD","LU0310800379.SGD","LU1934455277.USD","LU1023059063.AUD","LU0965509010.AUD","LU0689626769.HKD","LU0985320562.USD","LU1074936037.SGD","LU0861579265.USD","LU2468319806.SGD","LU0058720904.USD","BK4550","LU0943347566.SGD","LU2237443622.USD","LU0234572021.USD","LU2023251221.USD","LU1720051108.HKD","IE00BVYPNV92.GBP","LU2112291526.USD","LU0795875086.SGD","LU2125909247.SGD","LU1585245621.USD","LU1093756325.SGD","LU0310799852.SGD","IE00BVYPNW00.USD","SG9999001440.SGD","BK4534","LU2133065610.SGD","PPH","LU2357627491.SGD","LU2129689605.HKD","BK4566","LU0057025933.USD","IE00B19Z3B42.SGD","LU0868494617.USD","LU1839511570.USD","LU0456855351.SGD","LU1718418525.SGD","LU1236620834.HKD","LU0820561818.USD","IE00B42XCP33.USD","LU0170899867.USD","LU0417517546.SGD","LU1061106388.HKD","LU0795875169.SGD","LU1551013342.USD","LU2089984988.USD","LU1732799900.SGD","IE00BGHQF631.EUR","LU1244550221.USD","LU2237443465.HKD","XLV","LU2237443549.SGD","SG9999015986.USD","LU0912757837.SGD","AGNG","LU1923622614.USD","LU0949170772.SGD","IE0004445239.USD","IE00BBT3K403.USD","LU0545039389.USD","LU0553294199.USD","BK4581","IE00BFTCPJ56.SGD","LU1003077747.HKD","LU1496350502.SGD","LU2237443382.USD","LU0256863811.USD","LU2237443895.HKD","GLAM","LU2433249047.HKD","LU1057294990.SGD","LU0689472784.USD","LU1267930573.SGD","IE00B3PB1722.GBP","MEDX","LU0029864427.USD","IE0002141913.USD","IE000MB6IJN5.SGD","LU1236620750.USD","IE00BJJMRZ35.SGD","ABBV","JDOC","RXL","LU1430594728.SGD","LU1989772923.USD","LU2347655073.USD","SG9999015945.SGD","LU1720051017.SGD","BK4585","LU1929549753.HKD","LU1496350171.SGD","LU1162221912.USD","FTXH","LU1989771016.USD","LU0122379950.USD","SG9999003800.SGD","SG9999015978.USD","LU0868494708.USD","IE0009355771.USD","LU1037948541.HKD","LU2089283258.USD","BK4139","IE000BZT7R73.USD","FHLC","IE00BDGV0183.EUR","IE0002270589.USD","LU0289739343.SGD","LU0289739699.SGD","LU0882574055.USD","LU0128525929.USD","LU1291159041.SGD","IE00BN8TJ469.HKD","LU0859254822.USD","LU2089284900.SGD","LU2237443978.SGD","LU0211328371.USD","LU1548497426.USD","LU0198837287.USD","LU0820561909.HKD","LU0395794307.EUR","LU1244550494.USD","LU1244550577.SGD","LU0098860793.USD","LU2125909593.SGD","LU0965509101.SGD","BK4588","LU0726765562.USD","SG9999015952.SGD","LU0472753341.HKD","LU1093756168.USD","LU0738911758.USD","LU0114720955.EUR","IE00B4R5TH58.HKD","BK4559","IE000SO60NU8.SGD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574960","title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,461 Common Shares Worth $100,964.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574960","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574960?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:33","pubTimestamp":1790973213,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Legal Officer Soleil Boughton disposes of 3,461 common shares worth $100,964.37Soleil Boughton, Chief Legal Officer at Hims & Hers Health, sold 3,461 Class A common shares on Sept. 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7zp4VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,461 Common Shares Worth $100,964.37","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIYY","BK4196","HEAL","HIMZ","HIMC","HMYY","HIMS","HIMY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749671","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749671","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749671?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:32","pubTimestamp":1790973120,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rallied 1.11% to $262.82 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.The stock's rise snapped a three-day losing streak.AbbVie Inc. closed 2.44% below its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Amgen Inc.  fell 1.04% to $403.04.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU2089984988.USD","BK4139","PPH","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1551013425.SGD","IE00BFTCPJ56.SGD","IE0002270589.USD","LU1720051108.HKD","LU0234572021.USD","MEDX","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1244550494.USD","LU0069063385.USD","SG9999015986.USD","IYH","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU1496350171.SGD","LU2347655073.USD","LU2112291526.USD","LU2089284900.SGD","LU0289739343.SGD","LU0122379950.USD","BK4533","LU0211328371.USD","LU0114720955.EUR","LU0310799852.SGD","LU1989772923.USD","IE000F7OJYX1.SGD","LU2089283258.USD","LU0203345920.USD","LU1244550221.USD","LU0211327993.USD","LU0689626769.HKD","BK4588","LU0882574055.USD","LU0861579265.USD","IE0000B7K699.USD","LU0949170772.SGD","LU1720051017.SGD","LU0098860793.USD","IXJ","LU2129689514.USD","LU2129689605.HKD","LU0820561818.USD","LU0738911758.USD","BK4550","LU2433249047.HKD","LU1983299246.USD","LU0395794307.EUR","SG9999001440.SGD","SG9999003800.SGD","LU0256863902.USD","LU0965509283.SGD","LU1670628061.USD","LU1934455194.USD","LU2129689431.USD","IE00BVYPNV92.GBP","LU1236620834.HKD","LU1732799900.SGD","LU1839511570.USD","LU0472753341.HKD","LU2125909247.SGD","LU0289739699.SGD","IE000MB6IJN5.SGD","LU0942090050.USD","LU1093756325.SGD","LU0256863811.USD","LU1023059063.AUD","LU0058720904.USD","BK4585","LU0198837287.USD","LU0432979614.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU2237443465.HKD","LU0689472784.USD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU0057025933.USD","LU1236620750.USD","LU0203347892.USD","LU0985320562.USD","LU1162221912.USD","IE00B2B36J28.USD","LU0859254822.USD","LU2023251221.USD","LU0820561909.HKD","LU2087621335.USD","LU0417517546.SGD","BK4566","LU0029864427.USD","BK4559","VHT","LU0868494708.USD","LU1670627923.USD","LU0868494617.USD","AGNG","LU1061106388.HKD","FHLC","TRUH","IE00BLSP4239.USD","LU0158827948.USD","LU1585245621.USD","LU0320765646.SGD","LU2237443622.USD","LU1074936037.SGD","LU0965509101.SGD","LU2125909593.SGD","GLAM","LU0943347566.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU1732800096.USD","LU0545039389.USD","IE00B19Z3581.USD","IE000WAW04H5.SGD","IE0002141913.USD","PJP","LU1496350502.SGD","LU0726765562.USD","LU0795875086.SGD","IE0009355771.USD","SG9999015978.USD","IE00BVYPNW00.USD","LU1037948541.HKD","LU0553294199.USD","LU0456855351.SGD","LU0823416689.USD","LU0912757837.SGD","LU1057294990.SGD","LU1923622614.USD","LU2133065610.SGD","LU0708994859.HKD","LU1989771016.USD","LU1037948897.HKD","XLV","LU1093756168.USD","LU1244550577.SGD","LU1430594728.SGD","LU1548497426.USD","IE0004445239.USD","LU1003077747.HKD","LU0128525929.USD","LU2347655156.SGD","LU1718418525.SGD","LU0170899867.USD","LU1291159041.SGD","LU0511384066.AUD","LU2237443549.SGD","SG9999015945.SGD","LU0965508806.USD","LU1934455277.USD","BK4581","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0124676726.USD","JDOC","RXL","IE00BLSP4452.SGD","LU0965509010.AUD","IE00B42XCP33.USD","LU2357627491.SGD","LU0661504455.SGD","ABBV","LU1989772840.SGD","LU0289961442.SGD","LU1929549753.HKD","LU1934455863.HKD","LU2357305700.SGD","LU2237443895.HKD","IE00BGHQF631.EUR","IE000SO60NU8.SGD","LU1267930490.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","FTXH","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672474625","title":"Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar","url":"https://stock-news.laohu8.com/highlight/detail?id=2672474625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672474625?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:58","pubTimestamp":1790971113,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0YD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","AGNG","IE0002141913.USD","IE000WAW04H5.SGD","LU0158827948.USD","MEDX","FTXH","LU2237443895.HKD","IE00BSNM7G36.USD","TRUH","LU1037948897.HKD","LU1929549753.HKD","VHT","ABBV","LU0098860793.USD","LU2347655073.USD","LU1670628061.USD","LU0211328371.USD","LU0689626769.HKD","FHLC","LU1023059063.AUD","LU1732800096.USD","LU1989771016.USD","IE000F7OJYX1.SGD","IE00BVYPNV92.GBP","LU1267930490.SGD","XLV","IXJ","LU1074936037.SGD","SG9999015952.SGD","LU0170899867.USD","JDOC","GLAM","IYH","LU0234572021.USD","PJP","LU2347655156.SGD","LU0069063385.USD","LU1983299246.USD","LU2089283258.USD","LU0545039389.USD","PPH","LU2237443978.SGD","LU0203347892.USD","IE0004445239.USD","IE0002270589.USD","IE00BFTCPJ56.SGD","LU2129689431.USD","RXL","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672251746","title":"Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2672251746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672251746?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:58","pubTimestamp":1790971113,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","LU2347655073.USD","SG9999015986.USD","IE00B4R5TH58.HKD","MEDX","IE00BVYPNV92.GBP","BK4139","LU2237443978.SGD","IE00BLSP4452.SGD","LU1244550221.USD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU1720051017.SGD","IYH","IE00BJJMRZ35.SGD","FTXH","LU2112291526.USD","FHLC","LU0158827948.USD","LU1496350502.SGD","LU0058720904.USD","LU1923622614.USD","LU2129689431.USD","LU2347655156.SGD","LU0456855351.SGD","PJP","JDOC","BK4588","ABBV","XLV","LU0861579265.USD","LU1267930490.SGD","LU1983299246.USD","TRUH","RXL","LU0069063385.USD","SG9999003800.SGD","GLAM","LU1236620750.USD","VHT","AGNG","LU0511384066.AUD","IXJ","LU1244550577.SGD","LU1037948897.HKD","PPH","LU0114720955.EUR","LU0234572021.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672469877","title":"Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure","url":"https://stock-news.laohu8.com/highlight/detail?id=2672469877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672469877?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:27","pubTimestamp":1790969220,"startTime":"0","endTime":"0","summary":"Medtronic's $4 billion exchange offer for its shares of MiniMed Group is a lot less attractive now that MiniMed's stock has dropped since the offer was unveiled a couple of weeks ago.That could reduce","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU1145028129.USD","EKG","DXCM","LU2111349929.HKD","IE00B42XCP33.USD","LU0210536198.USD","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","IE00BLSP4239.USD","GLAM","SG9999002232.USD","VHT","BMED","MMED","LU2896262040.SGD","RSPS","IYH","HEAL","RXL","TRUH","LU1989764748.USD","LU0976567544.SGD","JDOC","MEDX","LU0234572021.USD","IE000M9KFDE8.USD","LU0029864427.USD","IE00B2B36J28.USD","LU1244550221.USD","JNJ","LU2129689431.USD","XLV","LU1043141396.HKD","KVUE","IE00BZ1G4Q59.USD","IHE","LU0098860793.USD","LU0354030511.USD","IE00BJT1NW94.SGD","PJP","IXJ","SG9999002224.SGD","FTXH","FHLC","GDOC","LU2089984988.USD","LU2505996509.AUD","MDT","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574634","title":"Kenvue (KVUE) Stock Still Looks Undervalued On Its 16% Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574634","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574634?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:28","pubTimestamp":1790965699,"startTime":"0","endTime":"0","summary":"Kenvue has delivered a 16.1% gain over the past year, even as shorter term returns have been softer. That naturally puts the focus on whether that move lines up with the cash the business can generate over time. With a Discounted Cash Flow (DCF) lens available, the key question is how closely the current US$17.22 share price aligns with the intrinsic value implied by those future cash streams.\n\nThe 16.1% return over the past year raises the question of whether Kenvue's recent share price...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/1820759186-card/1789222194240","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/1820759186-card/1789222194240"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/kenvue-kvue-stock-still-looks-undervalued-on-its-16-gain","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/kenvue-kvue-stock-still-looks-undervalued-on-its-16-gain","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","IE00B3T34201.USD","DCF","LU0128525929.USD","LU0708994859.HKD","GLAM","RSPS","SPHQ","IE00BFXG1179.USD","LU1267930813.SGD","KVUE","LU0792757196.USD","LU0029864427.USD","LU1267930573.SGD","BK4183","LU0889566641.SGD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743169","title":"AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743169","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743169?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958623,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest study, NCT05317494, tracks how its leukemia drug Venetoclax wor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH","VHT","LU2125909247.SGD","GLAM","FTXH","MEDX","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU0942090050.USD","LU0170899867.USD","LU1023059063.AUD","LU1989771016.USD","LU0395794307.EUR","LU1989772840.SGD","FHLC","IE00BLSP4452.SGD","ABBV","LU2129689605.HKD","LU0198837287.USD","LU0965509010.AUD","PJP","IXJ","LU0310800379.SGD","XLV","IE00BVYPNW00.USD","IE00B19Z3581.USD","RXL","IE00B42XCP33.USD","LU0289961442.SGD","TRUH","IE0002270589.USD","LU0310799852.SGD","LU0985320562.USD","JDOC","IYH","AGNG","LU2133065610.SGD","SG9999011175.SGD","LU1934455863.HKD","LU0234572021.USD","LU1244550494.USD","LU1839511570.USD","LU1732799900.SGD","LU0289739699.SGD","LU2023251221.USD","IE00BN8TJ469.HKD","ISBC","LU2237443549.SGD","LU2129689514.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BFSS8Q28.SGD","LU0225283273.USD","IE00BKVL7J92.USD","LU0109391861.USD","SG9999014898.SGD","LU1481599808.USD","LU0499090636.EUR","LU1993786604.SGD","LU0607220059.USD","LU0122379950.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BQJZX424.USD","LU1496350502.SGD","IE0008369823.USD","LU2360032135.SGD","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","NVOC","LU1273509221.SGD","LU1244550494.USD","LU2580892862.HKD","LU1035775433.USD","AZN.UK","SG9999004220.SGD","IE00BJT1NW94.SGD","LU2596442595.SGD","LU0053666078.USD","LU0889565080.SGD","LU0109981661.USD","LU2552382132.HKD","LU1116320737.USD","WDNA","LU1019634622.SGD","BK1161","LU0203202063.USD","LU0289739343.SGD","LU0889566641.SGD","LU0540923850.HKD","LU1720051017.SGD","LU2125154935.USD","IE00BKDWB100.SGD","LU1066051811.HKD","LU1974910355.USD","LU2129689605.HKD","LU0266013472.USD","LU0795875086.SGD","LU0823416689.USD","IE00B4JS1V06.HKD","LU2362541513.USD","LLYZ","LU0997586515.USD","LU2097828474.EUR","LU2362541273.HKD","BK0183","HK0000165453.HKD","LU2491050154.USD","PFE","IE00B19Z3B42.SGD","LU1983299246.USD","THNR","09995","LU1496350171.SGD","LU1807302812.USD","LU0323591593.USD","BK0196","LU2039709279.SGD","LU0154236417.USD","BK0012","LU1400636657.SGD","IE00B42XCP33.USD","LU0417516738.SGD","IE00BK4W5L77.USD","LU1019632923.USD","LU2028103732.USD","LU1551013425.SGD","LU2646069778.SGD","IE00BK4W5M84.HKD","LU0997586432.USD","LU0072913022.USD","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0965509283.SGD","LU1226288170.HKD","LU0096364046.USD","LU0345777147.USD","LU0472753341.HKD","LU0385154629.USD","LU1934455277.USD","BK1593","LU2091194634.USD","LU1989772840.SGD","LU0244354667.USD","LU1670756490.USD","SG9999014906.USD","IE000F7OJYX1.SGD","01093","LU1880407132.USD","BK4007","LU2750360997.AUD","LU0575583348.USD","LU0140636845.USD","KURE","BK1515","LU2236285917.USD","BNTX","LU1813983027.USD","LU0321505868.SGD","LU0158827948.USD","LU0238689110.USD","01801","IE0008368742.USD","LU2468319806.SGD","IE00BZ08YR35.GBP","BK4516","TRUH","LU2242652126.USD","LU0058720904.USD","LU1202635105.USD","AGNG","LU0942090050.USD","SG9999015986.USD","REGN","IE00BLSP4239.USD","BK1588","LU0158827781.USD","LU1003076772.USD","LU0784385840.USD","LU0211326839.USD","LU0784385170.HKD","LU0553294199.USD","LU0545562505.USD","LU2097828805.USD","LU2488822045.USD","LU1894683264.USD","LU0496365809.HKD","LU2125154778.USD","LU2237443382.USD","LU2462591350.SGD","GDOC","LU2097828714.EUR","02096","LU3187612489.SGD","LU0963555726.SGD","LU2360106947.USD","LU0784383803.USD","RHHBY","MEDI","IE00BFXG1179.USD","LU1585245621.USD","LU0985320562.USD","LU2471134879.HKD","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999017495.SGD","LU0237698245.USD","LU0070302665.USD","OZEM","688506","600276","LU2580892789.USD","LU0417516571.SGD","IE00B2B36J28.USD","LU0823434583.USD","LU0757432116.USD","IE0034235071.USD","LU0964806797.USD","LU2089283258.USD","LU1820825898.SGD","LU2347655073.USD","LU0211327993.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU0708994859.HKD","LU0161305163.EUR","LU2471134952.CNY","LU2750360641.GBP","IE00B5MMRT66.SGD","LU0820561818.USD","SG9999018865.SGD","LU0920783379.SGD","LU0267386448.USD","LU1066053197.SGD","VHT","LU1032466523.USD","LU0079474960.USD","IE00BGHQF631.EUR","IYH","LU2746668461.USD","IE00BKPKM643.USD","LU2087625088.SGD","LU2756315318.SGD","LU2476274308.USD","LU0149534421.HKD","BK4139","LU2087621335.USD","IBBQ","LU1152091168.USD","LU2097828631.EUR","LU2462157665.USD","LU1934455863.HKD","LU2063271972.USD","LU1146622755.USD","LU1064131003.USD","BK4581","LU1015430645.USD","LU1323610961.USD","LU2476274720.SGD","LU0011850046.USD","LU1145028129.USD","LU2433249047.HKD","LU0097036916.USD","LU0171293334.USD","LU1037948541.HKD","LU0857590862.USD","LU2552382058.USD","LU2023250504.SGD","LU1226287875.USD","LU0969580561.USD","IE00BZ08YT58.USD","MEDX","LU1153585028.USD","LU0689472784.USD","PJP","IE00BZ08YS42.EUR","LU0348825331.USD","LU0972486137.USD","NVS","LU0949170772.SGD","RXL","BK0060","LU1051770623.HKD","LU0162691827.USD","LU1064131342.USD","LU0225771236.USD","IE00BJJMRY28.SGD","LU1232071149.USD","LU1571399168.USD","LU1153584641.USD","LU0827474353.SGD","LU1670711040.USD","BK0239","LU0320765992.SGD","LU2756315664.SGD","LU0880133367.SGD","03692","LU1061106388.HKD","LU1794554557.SGD","ELIL","LU1868836914.USD","LU0920840948.USD","LU1804176565.USD","LU0501845795.SGD","BK5011","LU1720051108.HKD","LU0882574139.USD","LU2289578879.USD","LU2361044949.HKD","SGXZ99366536.SGD","LU2399975544.HKD","LU0987226296.USD","LU0980610538.SGD","PAWZ","09926","LU2106854487.HKD","LU0965508806.USD","IE00BJJMRX11.SGD","LU0069063385.USD","LU0124676726.USD","LU0320765059.SGD","LU1098665638.USD","IE0004445015.USD","LU1196032939.SGD","BK4548","CANC","LU1078025761.USD","LU1868836757.USD","LU1969619763.USD","LU1691799644.USD","SGXZ81514606.USD","LU0861579265.USD","LU0289961442.SGD","IE0000B7K699.USD","LU0466842654.USD","LU0310800965.SGD","LU2089984988.USD","LU1712237335.SGD","LU2133065610.SGD","LU0114720955.EUR","LU1037948897.HKD","LU2213496289.HKD","LU0320765646.SGD","LU2491049909.HKD","SG9999002232.USD","SG9999011175.SGD","SGXZ51526630.SGD","LU0405327148.USD","SG9999002224.SGD","LU0061475181.USD","LU1035773651.USD","LU0067412154.USD","BK0188","LU2237443465.HKD","IE00BWDBJ516.SGD","LU1057294990.SGD","LU1236620750.USD","LU1894683348.USD","LU1226287792.SGD","LU1255011170.USD","LU0133085943.USD","LU1670627923.USD","LU2108987350.USD","LU0557290698.USD","LU1580142542.USD","SG9999015945.SGD","IE00B3PB1722.GBP","LU2279689827.SGD","SGXZ57979304.SGD","LU0348784397.USD","LU2125909247.SGD","SG9999014914.USD","NVOH","BK4568","LU0211326755.USD","LU1829250122.USD","LU0390134368.USD","LU0683600562.USD","SG9999015952.SGD","LU0502904849.HKD","LU1023059063.AUD","IHE","LU2539964713.USD","LU2552382215.SGD","LU1481600234.SGD","IE0001KFT4U8.USD","LU0171276677.USD","LU2242646821.SGD","688331","LU1066051498.USD","LU0545039389.USD","SG9999015341.SGD","LU0316494557.USD","IE00BN29S564.USD","LU2211815571.USD","LU1064130708.USD","LU0348827113.USD","LU0726765562.USD","LU0128525689.USD","LU0348766576.USD","SG9999014567.USD","LU2125909593.SGD","LU0094547139.USD","LU1400636574.HKD","IE00B3M56506.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU0792757196.USD","IBB","LU1670628061.USD","LU2129689431.USD","SG9999001440.SGD","BK4585","LU0738911758.USD","LU0957799991.USD","LU0971552673.USD","LU2114397693.USD","LU1366192091.USD","SG9999014559.SGD","SG9999015358.SGD","SGXZ31699556.SGD","LLYX","LU1170363599.USD","SMMT","LU1035777561.USD","LU1328277881.USD","LU1267930227.SGD","LU1119994496.HKD","IE00BJLML261.HKD","SG9999001176.USD","LU2602419157.SGD","LU0912757837.SGD","LU1291159041.SGD","LU2111349929.HKD","LU1162221912.USD","LU0964807845.USD","LU0417517546.SGD","LU0648001328.SGD","LU0689626769.HKD","LU0310800379.SGD","LU0345770308.USD","LU0887340254.USD","LU1951186391.HKD","LU0130517989.USD","IE000BZT7R73.USD","LU1093756325.SGD","BK4533","LU1863844665.USD","LU0072461881.USD","BK0028","IE00BKPKM429.USD","LU0211331839.USD","LU0047473722.SGD","SG9999014542.SGD","BK1191","LU0106261372.USD","BMED","LU0130102774.USD","LU1430594728.SGD","LU1655091616.SGD","LU1645745479.HKD","LU0455707207.USD","LU0949170426.SGD","LU1046248800.SGD","SG9999001176.SGD","IE000MB6IJN5.SGD","LU0960981461.USD","LU2357627491.SGD","IE00BFTCPJ56.SGD","LU1863844749.USD","LU0234570918.USD","MHIP","BK1589","LU0471298694.HKD","GLAM","LU0395794307.EUR","LU2361045086.USD","LU1960683339.HKD","00013","IE0005OL40V9.USD","LU1839511570.USD","JDOC","LU0265550359.USD","LU2461242641.AUD","LU2324357040.USD","LU2112291526.USD","LU0057025933.USD","IE000SO60NU8.SGD","LU0077335932.USD","LU1074936037.SGD","LU0310799852.SGD","LU1629891620.HKD","LU0405327494.USD","LU0985481810.HKD","LU0795875169.SGD","LU1883839398.USD","LU0320765489.SGD","LU1997245177.USD","LU0321505439.SGD","LU1880407215.USD","IE00BDGV0183.EUR","LU0882574055.USD","LU0098860793.USD","LU0868494708.USD","LU2237443622.USD","IE00B19Z3581.USD","LU0820562030.AUD","LU0345777659.USD","LU1104425308.USD","LU1988902786.USD","LU2778985437.USD","TMED","LU2168564222.USD","LU2362540622.SGD","LU0174119429.USD","03933","LU0354030438.USD","LU0526926950.USD","LU0203347892.USD","LU1267930813.SGD","SG9999015978.USD","LU1989771016.USD","IE00BVYPNW00.USD","SG9999014575.USD","LU0820561909.HKD","LU1267930730.SGD","01530","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU0170899867.USD","LU1228905540.USD","LU0198837287.USD","LU1718418525.SGD","LU2168564149.EUR","03165","LU1355424745.HKD","LU0210536198.USD","LU1226287529.USD","IE00BWXC8680.SGD","LU2089284900.SGD","LU1720050803.USD","LU0859254822.USD","LU2357305700.SGD","LU0306806265.USD","LU1244550221.USD","FTXH","IE00BLSP4452.SGD","IE0009355771.USD","BMY","LU0256863902.USD","LU0315179316.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU1236620834.HKD","LU2023251221.USD","LU2271345857.HKD","GSK.UK","CURE","LU0353189680.USD","LU1309081286.SGD","LU0823434740.USD","ELIS","LU0029864427.USD","LU1066051225.USD","LU0477156953.USD","NVO","SG9999013999.USD","IE00BFSS7M15.SGD","IE00B3T34201.USD","IE0034235188.USD","LU1868836591.USD","LU2168564065.EUR","LU1979441026.SGD","LU1917777945.USD","BK4532","LU0225284248.USD","LU2023250843.SGD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B543WZ88.USD","ILDR","LU0256863811.USD","LU2495084118.USD","SG9999018857.SGD","LU1548497426.USD","LU1400636491.USD","LU1226288253.USD","LU1301847155.USD","HCM","LU2896262040.SGD","FHLC","LU0463099449.HKD","NVOX","LU0471298777.SGD","LU2242644610.SGD","IE0002270589.USD","LU2746668974.SGD","LU2023250330.USD","LU2293690082.USD","LLII","BK1587","IE00B031HY20.USD","IXJ","LU0889565916.HKD","ABBV","PPH","LU0203201768.USD","LU1732799900.SGD","BK1574","LU1152091754.HKD","LU1046234339.USD","LU2456880835.USD","LU1084165304.USD","LU1868837136.USD","LU1551013342.USD","LU1941712348.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","BK4551","LU0265550946.USD","LU0289739699.SGD","LU0787776722.HKD","LU1069347547.HKD","IE0004445239.USD","LU1188198961.HKD","LU2237443978.SGD","BK1521","HRTS","LU1732800096.USD","MRK","BK4592","LU0047473722.EUR","LU1116320901.HKD","LU1997244956.HKD","LU2129689514.USD","IE00BPRC5H50.USD","LU1069344957.HKD","LU0348767384.USD","LU0943347566.SGD","LU1328615791.USD","LU0306807586.USD","LU1929549753.HKD","BK4566","BK4550","LU2328871848.SGD","BK1583","LU0976567544.SGD","LU2355687059.USD","LU2237438978.USD","LU0511384066.AUD","LU1934455194.USD","BK4599","BK4534","LU1302929846.USD","BK4588","LU1127390331.HKD","TBXU","LU1487256676.USD","LU1670710661.SGD","LU1008478684.HKD","LU0348735423.USD","LU1064927863.SGD","LU0345770993.USD","LU0211328371.USD","LU0672654240.SGD","IE00B7KXQ091.USD","LU0965509101.SGD","BK4578","LU0786609619.USD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","BK4559","LU1093756168.USD","LU1267930573.SGD","BBH","IE000WAW04H5.SGD","LU1228905037.USD","01276","LU0823399737.USD","LU0234572021.USD","LU0868494617.USD","LU0561508036.HKD","LU1261432733.SGD","LU1699723380.USD","LU1831875114.USD","LU0326950275.SGD","LU0965509010.AUD","LU0417516902.SGD","LU1003077747.HKD","LU1781817850.SGD","LU1961090484.USD","LU2237443549.SGD","LU2471134523.USD","LU0784384876.USD","LU1989772923.USD","LU0640478417.SGD","IE00BSNM7G36.USD","LU0052756011.USD","LU2148510915.USD","IE0002141913.USD","SG9999014880.SGD","LU2471134796.USD","LU2417539215.USD","LU1670710588.SGD","LU0208291251.USD","LU0348783233.USD","IE00B1XK9C88.USD","LU1670711123.USD","LU2491050071.SGD","LLY","LU1923622614.USD","XLV","LU0314109678.HKD","LU1244550577.SGD","LU0634319403.HKD","GB00BDT5M118.USD","LU2237443895.HKD","LU1997245094.SGD","LU2293690249.USD","LU1941712264.USD","LU1267930490.SGD","LU2265009873.SGD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","LU0971552830.HKD","LU1868837300.USD","IE00BBT3K403.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU1720051108.HKD","LU2133065610.SGD","IBB","LU0069063385.USD","SNY","SNYNF","LU0098860793.USD","LU0211327993.USD","LU1917777945.USD","LU1244550577.SGD","OZEM","IYH","LU1037948541.HKD","PFE","LU0057025933.USD","LU1057294990.SGD","BBH","FTXH","TRUH","LU0417517546.SGD","MEDX","REGN","TBXU","PPH","LU0128525929.USD","LU2112291526.USD","AGNG","BK4599","XLV","LU0965509283.SGD","LU0949170772.SGD","LU0795875169.SGD","FHLC","LU0029864427.USD","IE00BJT1NW94.SGD","IXJ","VHT","LU0053666078.USD","LU0158827948.USD","IBBQ","JDOC","LU2347655073.USD","GLAM","LU1883839398.USD","RXL","BK4585","ABBV","LU0203347892.USD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABBV","LU2433249047.HKD","SPHQ","LU2468319806.SGD","LU0726765562.USD","LABU","LU2129689514.USD","LU1929549753.HKD","VHT","LU0256863902.USD","TRUH","LU1720051017.SGD","LU0965508806.USD","JDOC","LU1430594728.SGD","LU1670628061.USD","GLAM","LU1037948541.HKD","PPH","AGNG","LU2089284900.SGD","FHLC","BK4533","BK4139","LU0859254822.USD","LU1670627923.USD","LU2089984988.USD","LU0868494617.USD","LU1989772840.SGD","LU2125909593.SGD","BK4581","LU0114720955.EUR","LU2125909247.SGD","LU0472753341.HKD","LU0689626769.HKD","SG9999011175.SGD","LU2347655073.USD","IYH","RXL","FTXH","XLV","IXJ","LU0795875169.SGD","LU1244550221.USD","DCF","IE00B4R5TH58.HKD","PJP","BK4588","MEDX","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672768348","title":"AbbVie Says Phase 3 Trials Show Rinvoq Vitiligo Repigmentation Gains Extend to Week 76","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768348","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768348?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:02","pubTimestamp":1790863328,"startTime":"0","endTime":"0","summary":"AbbVie says Phase 3 trials show Rinvoq vitiligo repigmentation gains extend to week 76AbbVie disclosed long-term Phase 3 Viti-Up results for RINVOQ in non-segmental vitiligo, presented at the 2026 EAD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8fkyL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU0511384066.AUD","BK4559","PPH","LU0098860793.USD","TRUH","LU0965509101.SGD","IE00BLSP4239.USD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU2347655156.SGD","LU2357627491.SGD","MEDX","LU0417517546.SGD","JDOC","LU0256863902.USD","RXL","FHLC","LU1496350502.SGD","IE00BVYPNV92.GBP","IYH","LU1983299246.USD","LU2237443382.USD","LU0128525929.USD","LU0708994859.HKD","LU2237443895.HKD","FTXH","VHT","AGNG","PJP","LU1989771016.USD","LU1291159041.SGD","LU0198837287.USD","GLAM","ABBV","XLV","IE00BFTCPJ56.SGD","LU0289739343.SGD","LU0949170772.SGD","LU1023059063.AUD","LU1585245621.USD","BK4588","LU0661504455.SGD","LU0965508806.USD","IE000BZT7R73.USD","LU0553294199.USD","LU0320765646.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}